Anti-Titin/TTN monoclonal antibody
The Alternative Names of target: 1100001C23Rik,2310036G12Rik,2310057K23Rik,2310074I15Rik,CMD1G,CMH9,CMPD4,CMYO5,CMYP5,Connectin,D330041I19Rik,D830007G01Rik,EOMFC,HMERF,L56,LGMD2J,LGMDR10,MYLK5,Rhabdomyosarcoma antigen MU-RMS-40.14,SALMY,TMD,TTN,Titin,Ttn,connectin,mdm,shru
Pre-made anti-Titin/TTN monoclonal antibody (mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research.
Go
to Titin/TTN products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-MP1890-Ab-1/ GM-Tg-hg-MP1890-Ab-2 | Anti-Human Titin/TTN monoclonal antibody | Human |
| GM-Tg-rg-MP1890-Ab-1/ GM-Tg-rg-MP1890-Ab-2 | Anti-Rat Titin/TTN monoclonal antibody | Rat |
| GM-Tg-mg-MP1890-Ab-1/ GM-Tg-mg-MP1890-Ab-2 | Anti-Mouse Titin/TTN monoclonal antibody | Mouse |
| GM-Tg-cynog-MP1890-Ab-1/ GM-Tg-cynog-MP1890-Ab-2 | Anti-Cynomolgus/Rhesus macaque Titin/TTN monoclonal antibody | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-MP1890-Ab-1/ GM-Tg-felg-MP1890-Ab-2 | Anti-Feline Titin/TTN monoclonal antibody | Feline |
| GM-Tg-cang-MP1890-Ab-1/ GM-Tg-cang-MP1890-Ab-2 | Anti-Canine Titin/TTN monoclonal antibody | Canine |
| GM-Tg-bovg-MP1890-Ab-1/ GM-Tg-bovg-MP1890-Ab-2 | Anti-Bovine Titin/TTN monoclonal antibody | Bovine |
| GM-Tg-equg-MP1890-Ab-1/ GM-Tg-equg-MP1890-Ab-2 | Anti-Equine Titin/TTN monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-MP1890-Ab-1/ GM-Tg-hg-MP1890-Ab-2;
GM-Tg-rg-MP1890-Ab-1/ GM-Tg-rg-MP1890-Ab-2;
GM-Tg-mg-MP1890-Ab-1/ GM-Tg-mg-MP1890-Ab-2; GM-Tg-cynog-MP1890-Ab-1/ GM-Tg-cynog-MP1890-Ab-2; GM-Tg-felg-MP1890-Ab-1/ GM-Tg-felg-MP1890-Ab-2; GM-Tg-cang-MP1890-Ab-1/ GM-Tg-cang-MP1890-Ab-2; GM-Tg-bovg-MP1890-Ab-1/ GM-Tg-bovg-MP1890-Ab-2; GM-Tg-equg-MP1890-Ab-1/ GM-Tg-equg-MP1890-Ab-2 |
| Products Name | Anti-Titin/TTN monoclonal antibody |
| Format | mab |
| Target Name | Titin/TTN |
| Protein Sub-location | Transmembrane Protein |
| Category of antibody | |
| Derivation (species) | Mouse |
| CH1+2+3 Isotype (Receptor identification) |
IgG |
| Type of Light Chain (VD-LC) | N/A |
| Expression platform | Mammalian Expression |
| Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
| Tag | Fc |
| Products description | Pre-made anti-Titin/TTN monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.